BrewDog is offering its 1,800 UK employees a new mental health referral service.
The initiative gives staff the opportunity to be assessed and diagnosed for autism and attention deficit hyperactivity disorder (ADHD).
Through a partnership with mental healthcare company Onebright, the neurodiversity assessment will include an appraisal of medical history, family history and systems to establish whether they have either condition. Those who do will receive advice and signposting towards treatments, which will include cognitive behavioural Therapy.
Karen Bates, chief people officer at BrewDog, said: “We are aware a proportion of our employees are likely to be neurodivergent and that some of these individuals will be without diagnosis. Only recently our CEO James Watt spoke out about his recent autism and ADHD diagnosis at the age of 40.
“This year, we have increased the mental health programmes that our employees can access, and we are really pleased to have partnered with Onebright to provide world leading clinical expertise and strategic guidance on our neurodivergent mental health provision.”
